Table 1 Treatment of anaphylactic reaction in PRE-s and POST-s period
Medications | 2004–2010 (n; %) | 2011–2016 (n; %) | p | |
|---|---|---|---|---|
Anthistamines | Pre-PED | 23;28 | 40;43 | >Â 0.05 |
In-PED | 44;54 | 99;70 | <Â 0.05 | |
Corticosteroids | Pre-PED | 31;39 | 59;30 | >Â 0.05 |
In-PED | 49;60 | 95;73 | <Â 0.05 | |
Bronchodilatators | Pre-PED | 14;17 | 10;7 | <Â 0.05 |
In-PED | 18;22 | 18;13 | >Â 0.05 | |
Epinephine IM | Pre-PED | 5;6 | 8;6 | >Â 0.05 |
In-PED | 1;2, 4 | 6;10 | <Â 0.05 | |
No treatment | Pre-PED | 35;43 | 48;73 | >Â 0.05 |
In-PED | 19;23 | 12;30 | <Â 0.05 | |
Oxigen | Pre-PED | np | np | – |
In-PED | np | 5; 4 | > 0.05 | |
Fluid IV | Pre-PED | np | 3; 33 | > 0.05 |
In-PED | np | 33; 24 | < 0.05 | |
Epinephrine aerosol | Pre-PED | np | 3; 2 | > 0.05 |
In-PED | np | 1; 0.7 | > 0.05 | |